Dr. Ali Chaari holds a degree in engineering biology from the National Engineering School in Tunisia and a PhD in biochemistry and biophysics from Versailles University, France where he studied the regulation of amyloid aggregation in neurodegenerative diseases. Subsequently, he conducted postdoctoral biochemistry research training at WCM-Q in the laboratory of Dr. Moncef Ladjimi.
During his PhD in France, Dr. Chaari began teaching biochemistry and molecular biology as a teaching assistant and also as a temporary assistant of education and research (ATER). When he joined WCM-Q as a post-doc he volunteered to teach first-year medical students. In 2015, Dr. Chaari decided to dedicate more time to teaching, so he joined the biology support teaching team in the Division of Pre-medical Education.
In addition to his teaching role as a teaching specialist for biology and biochemistry courses, he is involved in several outreach programs and contributed to the development and delivery of the new pre-medical biochemistry curriculum. In the future, besides his current teaching duties, he will be developing and teaching a new biochemistry course.
Dr. Chaari is experienced in biochemistry, molecular biology, and biophysics. In 2015, he was awarded a grant from Qatar National Research Fund to lead a study on chaperone interaction with amylin peptide in type 2 diabetes. He has co-authored several original research articles, written two books and has presented his work at several conferences. In addition, he is active as a research mentor to WCM-Q's medical students. One of his active areas of research is the study of amyloid proteins modulation in neurodegenerative diseases and diabetes.
- Chaari A, Eliezer D, Ladjimi M. The C-terminal alpha-helices of mammalian
Hsc70 play a critical role in the stabilization of alpha-synuclein binding and
inhibition of aggregation. Int J Biol Macromol. 2016 Feb;83:433-41.
- Chaari A, Fahy C, Chevillot-Biraud A, Rholam M. Insights into Kinetics of
Agitation-Induced Aggregation of Hen Lysozyme under Heat and Acidic Conditions
from Various Spectroscopic Methods. PloS one. 2015;10(11):e0142095.
- Chaari A, Hoarau-Vechot J, Ladjimi M. Applying chaperones to
protein-misfolding disorders: molecular chaperones against alpha-synuclein in
Parkinson's disease. Int J Biol Macromol. 2013 Sep;60:196-205.
Chaari A, Horchani H, Frikha F, Verger R, Gargouri Y, Ladjimi M. Surface
behavior of alpha-Synuclein and its interaction with phospholipids using the
Langmuir monolayer technique: a comparison between monomeric and fibrillar
alpha-Synuclein. Int J Biol Macromol. 2013 Jul;58:190-8.
. Chaperones as a
Novel Target Against Amyloids in Parkinson’s Disease: LAP LAMBERT Academic
Chaari A. Produits Naturels VERSUS Amyloides et Amyloses:
Produits naturels et maladies Dégénératives Presses Académiques Francophones;